These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 16600114

  • 1. [Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis].
    Yuan BJ, Liu ZZ, Ding XR, Zou JM.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):96-8. PubMed ID: 16600114
    [Abstract] [Full Text] [Related]

  • 2. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
    Fu Y, Xiao QM, Wang T, Chen XH, Ai YH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
    Jun EJ, Han JY, Sun HS.
    Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
    [Abstract] [Full Text] [Related]

  • 4. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W, Izycki T, Ossolinska M, Chyczewska E.
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of soluble fas and soluble fas ligand in serum of patients with complete hydatidiform moles.
    Soni S, Rath G, Deval R, Salhan S, Mishra AK, Saxena S.
    Am J Reprod Immunol; 2011 Sep; 66(3):230-6. PubMed ID: 21385271
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of soluble Fas ligand in patients with silicosis.
    Tomokuni A, Otsuki T, Isozaki Y, Kita S, Ueki H, Kusaka M, Kishimoto T, Ueki A.
    Clin Exp Immunol; 1999 Dec; 118(3):441-4. PubMed ID: 10594565
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of the sFas/sFasL system in psoriatic patients.
    Myśliwiec H, Baran A, Myśliwiec P, Górska M, Flisiak I.
    Adv Med Sci; 2015 Mar; 60(1):64-8. PubMed ID: 25437350
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Expression and clinical significance of CD4(+)CD25(+)Treg cells, sFas and sFasL in peripheral blood of patients with autoimmune thrombocytopenic purpura].
    Jia RP, Zhao XY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1264-7. PubMed ID: 22040985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum and follicular fluid levels of soluble Fas and soluble Fas ligand in IVF cycles.
    Onalan G, Selam B, Onalan R, Ceyhan T, Cincik M, Pabuccu R.
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar 01; 125(1):85-91. PubMed ID: 16140454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia.
    Fathi M, Amirghofran Z, Shahriari M.
    Med Oncol; 2012 Sep 01; 29(3):2046-52. PubMed ID: 21528407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.